These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: a putative marker of an ongoing inflammatory process. McRae A; Martins RN; Fonte J; Kraftsik R; Hirt L; Miklossy J Exp Gerontol; 2007 Apr; 42(4):355-63. PubMed ID: 17140756 [TBL] [Abstract][Full Text] [Related]
49. Alzheimer's Disease Research Using Human Microglia. Lue LF; Beach TG; Walker DG Cells; 2019 Aug; 8(8):. PubMed ID: 31387311 [TBL] [Abstract][Full Text] [Related]
50. The evolving biology of microglia in Alzheimer's disease. Malm TM; Jay TR; Landreth GE Neurotherapeutics; 2015 Jan; 12(1):81-93. PubMed ID: 25404051 [TBL] [Abstract][Full Text] [Related]
51. Microglia as a potential bridge between the amyloid beta-peptide and tau. Kitazawa M; Yamasaki TR; LaFerla FM Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802 [TBL] [Abstract][Full Text] [Related]
52. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model. Guedes JR; Custódia CM; Silva RJ; de Almeida LP; Pedroso de Lima MC; Cardoso AL Hum Mol Genet; 2014 Dec; 23(23):6286-301. PubMed ID: 24990149 [TBL] [Abstract][Full Text] [Related]
53. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist. Ardestani PM; Evans AK; Yi B; Nguyen T; Coutellier L; Shamloo M Neuropharmacology; 2017 Apr; 116():371-386. PubMed ID: 28089846 [TBL] [Abstract][Full Text] [Related]
54. Developmental toxicant exposure in a mouse model of Alzheimer's disease induces differential sex-associated microglial activation and increased susceptibility to amyloid accumulation. vonderEmbse AN; Hu Q; DeWitt JC J Dev Orig Health Dis; 2017 Aug; 8(4):493-501. PubMed ID: 28460650 [TBL] [Abstract][Full Text] [Related]
55. Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review. Park JC; Han SH; Mook-Jung I BMB Rep; 2020 Jan; 53(1):10-19. PubMed ID: 31865964 [TBL] [Abstract][Full Text] [Related]
56. Microglial Function and Regulation during Development, Homeostasis and Alzheimer's Disease. Casali BT; Reed-Geaghan EG Cells; 2021 Apr; 10(4):. PubMed ID: 33924200 [TBL] [Abstract][Full Text] [Related]
58. Glial activation and inflammation along the Alzheimer's disease continuum. Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945 [TBL] [Abstract][Full Text] [Related]
59. Role of the peripheral innate immune system in the development of Alzheimer's disease. Le Page A; Dupuis G; Frost EH; Larbi A; Pawelec G; Witkowski JM; Fulop T Exp Gerontol; 2018 Jul; 107():59-66. PubMed ID: 29275160 [TBL] [Abstract][Full Text] [Related]
60. Beclin1-driven autophagy modulates the inflammatory response of microglia via NLRP3. Houtman J; Freitag K; Gimber N; Schmoranzer J; Heppner FL; Jendrach M EMBO J; 2019 Feb; 38(4):. PubMed ID: 30617086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]